Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-012925
Filing Date
2013-03-05
Accepted
2013-03-05 16:03:12
Documents
2
Period of Report
2013-03-05

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER v337173_6k.htm 6-K 17318
2 PRESS RELEASE v337173_ex99-1.htm EX-99.1 10574
  Complete submission text file 0001144204-13-012925.txt   28896
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 000-54749 | Film No.: 13665644
SIC: 2834 Pharmaceutical Preparations